139 related articles for article (PubMed ID: 6979361)
1. Enzymatic activities of activated and zymogen forms of human Hageman factor (factor XII).
Silverberg M; Kaplan AP
Blood; 1982 Jul; 60(1):64-70. PubMed ID: 6979361
[TBL] [Abstract][Full Text] [Related]
2. The autoactivation of rabbit Hageman factor.
Wiggins RC; Cochrane CC
J Exp Med; 1979 Nov; 150(5):1122-33. PubMed ID: 501286
[TBL] [Abstract][Full Text] [Related]
3. Sulfatide-dependent autoactivation of human blood coagulation Factor XII (Hageman Factor).
Tans G; Rosing J; Griffin JH
J Biol Chem; 1983 Jul; 258(13):8215-22. PubMed ID: 6553053
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
[TBL] [Abstract][Full Text] [Related]
5. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.
Mandle R; Kaplan AP
J Biol Chem; 1977 Sep; 252(17):6097-104. PubMed ID: 408348
[TBL] [Abstract][Full Text] [Related]
6. A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein.
Kaplan AP; Kay AB; Austen KF
J Exp Med; 1972 Jan; 135(1):81-97. PubMed ID: 5009705
[TBL] [Abstract][Full Text] [Related]
7. Endothelial cells produce a substance that inhibits contact activation of coagulation by blocking the activation of Hageman factor.
Kleniewski J; Donaldson VH
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):198-202. PubMed ID: 8419923
[TBL] [Abstract][Full Text] [Related]
8. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
Revak SD; Cochrane CG; Griffin JH
J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay.
Kaplan AP; Gruber B; Harpel PC
Blood; 1985 Sep; 66(3):636-41. PubMed ID: 3875374
[TBL] [Abstract][Full Text] [Related]
10. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
Tans G; Janssen-Claessen T; Rosing J; Griffin JH
Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
[TBL] [Abstract][Full Text] [Related]
11. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).
Cochrane CG; Wuepper KD
J Exp Med; 1971 Oct; 134(4):986-1004. PubMed ID: 4106492
[TBL] [Abstract][Full Text] [Related]
12. The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein.
Dunn JT; Silverberg M; Kaplan AP
J Biol Chem; 1982 Feb; 257(4):1779-84. PubMed ID: 6915937
[TBL] [Abstract][Full Text] [Related]
13. Formation and structure of human Hageman factor fragments.
Dunn JT; Kaplan AP
J Clin Invest; 1982 Sep; 70(3):627-31. PubMed ID: 6921203
[TBL] [Abstract][Full Text] [Related]
14. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
España F; Ratnoff OD
J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
[TBL] [Abstract][Full Text] [Related]
15. The effect of C1 inhibitor upon Hageman factor autoactivation.
Weiss R; Silverberg M; Kaplan AP
Blood; 1986 Jul; 68(1):239-43. PubMed ID: 3487356
[TBL] [Abstract][Full Text] [Related]
16. The Hageman factor-dependent system in the vascular permeability reaction.
Yamamoto T; Kozono K; Kambara T; Cochrane CG
Biochim Biophys Acta; 1988 Aug; 966(2):196-206. PubMed ID: 3401504
[TBL] [Abstract][Full Text] [Related]
17. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
Meier HL; Pierce JV; Colman RW; Kaplan AP
J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Hageman factor (factor XII) by popcorn inhibitor.
Kambhu SA; Ratnoff OD; Everson B
J Lab Clin Med; 1985 May; 105(5):625-8. PubMed ID: 3989356
[TBL] [Abstract][Full Text] [Related]
19. Fluid phase activation of Hageman factor (factor XII) in citrated human plasma by bromelain: an application to the indirect enzymatic assay for Hageman factor.
Oh-ishi S
Thromb Res; 1982 Sep; 27(5):619-23. PubMed ID: 6983741
[No Abstract] [Full Text] [Related]
20. Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate.
Bouma BN; Miles LA; Beretta G; Griffin JH
Biochemistry; 1980 Mar; 19(6):1151-60. PubMed ID: 6768384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
